Cal-Maine Foods Stock Slips on Surprise Q4 Loss

Cal-Maine Foods (NASDAQ:CALM) shares fell after the company reported a fiscal Q4 loss of 76 cents per share, versus analysts expecting a profit of 11 cents. The firm cited historically low inflation-adjusted egg prices. Revenue dropped 49.9% year over year to $552.6 million. Stock was down 2.7% near $84.96.

Original reporting
Published Jul 22, 2026, 2:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 4:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine Foods Stock Slips on Surprise Q4 Loss — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

A profit miss plus nearly 50% year-over-year revenue decline can reset near-term expectations for the egg producer and keep bearish positioning elevated.

02

Market read

Traders can reassess CALM’s near-term earnings power and volatility expectations based on the reported EPS and revenue figures.

03

What to watch

The article does not quantify guidance or balance-sheet changes, so traders may be reacting to earnings optics rather than forward fundamentals.

Relevance 8/10Novelty 6/10Timing: this morning after the fiscal Q4 results print

Background

The piece frames CALM’s fiscal Q4 as a surprise loss driven by historically low inflation-adjusted egg prices.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine reported a surprise fiscal Q4 loss of 76 cents per share, missing expectations for a profit of 11 cents.

Expected impact

Near-term bias to weakness, with elevated bearish options sentiment potentially amplifying volatility.

Evidence & confidence

The article provides the EPS miss, revenue decline, and notes bearish put/call ratios plus a volatility score suggesting moves may be overestimated.

Market effects

Signals continued pricing pressure in egg markets tied to inflation-adjusted egg price weakness.

Primarily impacts US food/agri supply chain sentiment around protein pricing.

Limited direct global spillover; mostly a US consumer staples and agriculture read-through.

Counterpoint

Despite the miss, the SVS indicates options traders may be overestimating move magnitude, which can cap downside if selling is crowded.

Key entities

  • Cal-Maine Foods

    Egg producer reporting a surprise fiscal Q4 loss and revenue decline.

Related articles

$CALMMedAI 8/10

Why Cal-Maine Foods Stock Just Cracked

Cal-Maine Foods (NASDAQ: CALM) shares fell about 3.7% by 9:45 a.m. ET after reporting Q4 results. Analysts expected EPS of $0.11 on $657M sales, but the company reported a loss of $0.76 per share on $552.6M sales. CEO Sherman Miller cited industry oversupply and low wholesale egg prices. 2026 revenue fell 32% and profit fell 73%.

$CALMMedAI 8/10

Cal-Maine Falls To Loss In Q4, Shares Down

Cal-Maine Foods (CALM) reported a Q4 2026 net loss of $35.88 million versus a $342.48 million profit a year earlier. Net loss per share was $0.76 versus EPS of $7.01. Revenue fell 49.9% to $552.58 million from $1.10 billion. Shares were down about 4.69% premarket to $83.16 on Nasdaq.

$SMCIMed

Stocks making the biggest moves premarket: Super Micro Computer, GE Vernova, Rocket Lab and more

Premarket movers included Super Micro Computer, up about 17% after preliminary Q4 results showed stronger profitability than expected, with revenue near low guidance. GE Vernova fell over 7% despite a revenue beat and raised full-year guidance. Rocket Lab rose about 4% on a $266 million U.S. Air Force contract. Pegasystems dropped over 14% after Q2 missed estimates; others moved on earnings or nuclear/AI news.

$CALMMed

Maine (NASDAQ:CALM) Misses Q2 CY2026 Sales Expectations

Cal-Maine Foods (NASDAQ: CALM) reported Q2 CY2026 revenue of $552.6 million, down 49.9% year over year, missing market expectations. The company posted a GAAP loss of $0.76 per share, better than analysts’ consensus. Management cited strategy to improve product mix and pricing. The stock fell 2.2% to $85.37 after results.